Effects Of Down-Dog Yoga On Pain And Posture In Children With Nonspecific Low Back Pain

December 29, 2025 updated by: Riphah International University

To manage back pain and correct postural imbalances in children, Downward-Facing Dog (Adho Mukha Svanasana) promotes flexibility, core strength, and spinal alignment.

Traditional physiotherapy may seem repetitive and less engaging for kids. Yoga offers a developmentally appropriate, non-invasive, and enjoyable alternative. Studying its effectiveness could provide a simple, affordable, and accessible therapy option.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

School-aged children are increasingly experiencing nonspecific low back pain (NSLBP) as a result of sedentary lifestyles, bad posture, and inactivity. This illness frequently results in discomfort, decreased engagement in physical activities, and a lower standard of living. Preventing chronic pain and long-term incapacity requires early intervention.

The benefits of yoga as a physical and mental treatment for musculoskeletal issues are becoming more widely acknowledged. A basic yoga stance that develops the core muscles, improves spinal alignment, and extends the body's posterior chain is the Down-Dog pose. Research on its use in the paediatric population is few, despite the fact that its advantages in adults are widely established. The purpose of this study is to investigate how well Down-Dog yoga helps children with NSLBP with their pain management and posture. Participants in this randomized controlled experiment will be school-age children (8-14 years old) with a clinical diagnosis of nonspecific low back pain. A control group will get traditional stretching and posture correction activities, while an experimental group will practice Down-Dog yoga. Participants will be randomly assigned to either group.

During a six-week period, both interventions will be given three times a week for 30 minutes each. The Plumb Line Test and Modified Schober's Test will be used to assess postural alignment, and the Visual Analog Scale (VAS) will be used to gauge pain levels.

Children's everyday functioning will be evaluated as a result of the intervention using the Paediatric Quality of Life Inventory (PedsQL). Data will be gathered both before and after the intervention, and the proper statistical methods will be used for analysis.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
58

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Children aged 8 to 14 years Actively enrolled in a regular school setting. Clinical diagnosis of non-specific low back pain Pain duration of at least 4 weeks but less than 6 months. Self-reported pain of ≥3 on a 10-point Visual Analog Scale or age-appropriate pain scale Presence of observable postural misalignment

Exclusion Criteria:

History or evidence of spinal deformity Structural abnormalities History of neuromuscular disorders, cerebral palsy, or epilepsy Trauma, fractures, or surgery to the spine or lower limbs in the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Down dog yoga with routine physical therapy group

Warm-Up Complementary Yoga Poses

Other supportive poses will be integrated to enhance the effects of Down-Dog Yoga:

Child's Pose Cool Down and Relaxation
Other: down dog yoga
experimenbtal group was given down dog yoga protocol along with back and trunk isometric and trunk streching control group wasa givcen standard phyiotherapy intervention total 2 session will given each week consisting of 30 mints
Other Names:
  • No intervention
Active Comparator: Routine physical therapy group
The control group will receive standard conventional physiotherapy designed for the management of nonspecific low back pain in children. This intervention focuses on general stretching, strengthening, and postural correction exercises that are commonly used in clinical pediatric rehabilitation Warm-Up Bird-dog Gentle stretching: Focus on back, hips, and hamstrings Deep breathing and relaxation: In seated or lying down position
Other: down dog yoga
experimenbtal group was given down dog yoga protocol along with back and trunk isometric and trunk streching control group wasa givcen standard phyiotherapy intervention total 2 session will given each week consisting of 30 mints
Other Names:
  • No intervention

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
plumb line for posture correction
Time Frame: Baseline and after 6 weeks
the individual stands upright next to a vertical plumb line (or against a grid or wall) so that their posture can be visually evaluated. Key anatomical landmarks such as the ear lobe, shoulder, hip, knee, and ankle are observed in relation to the plumb line to detect deviations from normal alignment. It is a non-invasive, quick, and cost-effective method commonly used in physiotherapy and rehabilitation settings to identify postural imbalances.
Baseline and after 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: muhammad haroon, dpt, Riphah International University, Lahore

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 20, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 20, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 20, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 29, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 29, 2025

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 12, 2026

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 12, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 29, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • MUHAMMAD HAROON UR RAHMAN

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings